The role of mucin-type O-glycans in eukaryotic development

Seminars in Cell and Developmental Biology

Volumn 21, Issue 6, 2010, Pages 616-621

  Tabak, Lawrence A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Glycosyltransferases; Mucin type O glycosylation; Mucins; O glycans; UDP GalNAc:polypeptide N acetylgalactosaminyltransferases

Indexed keywords

CARBOHYDRATE; GLYCAN DERIVATIVE; GLYCOSIDE; GLYCOSYLTRANFERASE; MUCIN; O GLYCAN DERIVATIVE; TRANSFERASE; UNCLASSIFIED DRUG;

CELL MATURATION; CONGENITAL DISORDER; EUKARYOTIC CELL; GENE LOCATION; GENE MAPPING; GENE STRUCTURE; IN VIVO STUDY; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW;

EUKARYOTA;

EID: 77955279149     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2010.02.001     Document Type: Review

References (100)

1. Bennett H.S. Morphological aspects of extracellular polysaccharides. J Histochem Cytochem 1963, 11:14-23.
2. Martinez-Palomo A. The surface coats of animal cells. Intl Rev Cytol 1970, 29:29-75.
3. Bourrillon R., Aubery M. Cell surface glycoproteins in embryonic development. Intl Rev Cytol 1989, 116:257-338.
4. Roseman S. Reflections on glycobiology. J Biol Chem 2001, 276:41527-41542.
5. Hakomori S. The glycosynapse. Proc Natl Acad Sci 2002, 99:225-232.
6. Bucior I., Burger M.M. Carbohydrate-carbohydrate interactions in cell recognition 2004, 14:631-637.
7. Tabak L.A., Levine M.J., Mandel I.D., Ellison S.A. Role of salivary mucins in the protection of the oral cavity. J Oral Path 1982, 11:1-17.
8. Tabak L.A. In defense of the oral cavity: structure, biosynthesis and function of salivary mucins. Annu Rev Physiol 1995, 57:547-564.
9. Rose M.C., Voynow J.A. Respiratory tract mucin genes and mucin glycoproteins in health disease. Physiol Rev 2006, 86:245-278.
10. Lang T., Hansson G.C., Samuelsson T. Gel-forming mucins appeared early in metazoan development. Proc Natl Acad Sci 2007, 104:16209-16214.
11. Hollingsworth M.A., Swanson B.J. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004, 4:45-60.
12. Desseyn J.-L., Tetaert D., Gouyer V. Architecture of the large membrane-bound mucins. Gene 2008, 410:215-222.
13. Daley W.P., Peters S.B., Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 2008, 121:25-264.
14. Rozario T, DeSimone DW. The extracellular matrix in development and morphogenesis: A dynamic view. Dev Biol 2009, doi:10.1016/j.ydbio.2009.10.026.
15. Dharmani P., Srivastava V., Kissoon-Singh V., Chadee K. Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immunity 2009, 1:123-135.
16. Hang H.C., Bertozzi C.R. The chemistry and biology of mucin-type O-linked glycosylation. Bioorg Med Chem 2005, 13:5021-5034.
17. Tarp M.A., Clausen H. Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim Biophys Acta 2008, 1780:546-563.
18. Tian E., Ten Hagen K.G. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J 2009, 26:325-334.
19. Ten Hagen K.G., Fritz T.A., Tabak L.A. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 2003, 13:1R-16R.
20. Raman et al., submitted for publication.
21. Tian E., Ten Hagen K.G. Expression of UPD-GalNAc:polypeptide N-acetylgalactosaminyltransferase family is spatially and temporally regulated during Drosophila development. Glycobiology 2006, 16:83-95.
22. Kingsley P.D., Ten Hagen K.G., Maltby K.M., Zara J., Tabak L.A. Diverse spatial expression patterns of UPD-GalNAc:polypeptide N-acetylgalactosaminyltransferase family member mRNAs during mouse development. Glycobiol 2000, 10:1317-1323.
23. Hagen F., Layden M., Nehrke K., Gentile K., Berbach K., Tsao C.C., et al. Trends Glycosci Glycotech 2001, 13:463-479.
24. Miwa H.E., Gerkin T.A., Jamison O., Tabak L.A. Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1. J Biol Chem 2010, 285:1208-1219.
25. Ten Hagen K.G., Tetaert D., Hagen F.K., Richet C., Beres T.M., Gagnon J., et al. Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyl-transferase that displays glycopeptide N-acetylgalactosaminyltransferase activity. J Biol Chem 1999, 274:27867-27874.
26. Hassan H., Reis C.A., Bennett E.P., Mirgorodskaya E., Roepstorff P., Hollingsworth M.A., et al. The lectin domain of UDP-N-acetyl-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities. J Biol Chem 2000, 275:38197-38205.
27. Ten Hagen K.G., Bedi G.S., Tetaert D., Kingsley P.D., Hagen F.K., Balys M.M., et al. Cloning and characterization of a ninth member of the UDP-GalNAc:polypeptide N acetylgalactosaminyl-transferase family, ppGaNTase-T9. J Biol Chem 2001, 276:17395-17404.
28. Pratt M.R., Hang H.C., Ten Hagen K.G., Rarick J., Gerkin T.A., Tabak L.A., et al. Deconvoluting the functions of the polypeptide N-α-acetylgalactosaminyltransferase family members by glycopeptides substrate profiling. Chem Biol 2004, 11:1009-1016.
29. Gerkin T.A., Ten Hagen K.G., Jamison O. Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc trasnferase ortholog pairs. Glycobiology 2008, 18:861-870.
30. Holmen Larsson J.M., Karlsson H., Sjovall H., Hannson G.C. A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MS. Glycobiology 2009, 19:756-766.
31. Kabat E.A., Bassett E.W., Pryzwansky K., Lloyd K.O., Kaplan M.E., Layug E.J. Immunochemical studies on blood groups. XXXIII. The effects of alkaline borohydride and of alkali on blood group A, B and H substances. Biochemistry 1965, 4:1632-1638.
32. Rosen S.D. Ligands for L-selectins: Homing, inflammation and beyond. Annu Rev Immunol 2004, 22:129-156.
33. Tenno M., Ohtsubo K., Hagen F.K., Ditto D., Zarbock A., Schaerli P., et al. Initiation of protein O-glycosylation by the polypeptide GalNAcT-1 in vascular biology and humural immunity. Mol Cell Biol 2007, 27:8783-8796.
34. Murray P.A., Levine M.J., Tabak L.A., Reddy M.S. Specificity of salivary-bacterial interactions: II. Evidence for a lectin on Streptococcus sanguis with specificity for NeuAcα2,3Galβ1,3GalNAc sequence. Biochem Biophys Res Commun 1982, 106:390-396.
35. Boren T., Falk P., Roth K.A., Larson G., Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993, 262:1892-1895.
36. Jentoft N. Why are proteins O-glycosylated?. Trends Biochem Sci 1990, 15:291-294.
37. Collins B.E., Paulson J.C. Cell surface biology mediated by low affinity multivalent protein-glycan interactions. Curr Opin Chem Biol 2004, 8:1-9.
38. Dam T.K., Gerken T.A., Cavada B.S., Nascimento K.S., Moura T.R., Brewer C.F. Binding studies of α-GalNAc-specific lectins to the a-GalNAc (Tn-antigen) forms of porcine submaxillary mucin and its smaller fragments. J Biol Chem 2007, 282:28256-28263.
39. Rastan S., Thorpe S.J., Scudder P., Brown S., Gooi H.C., Feizi T. Cell interactions in preimplantation embryos: evidence for involvement of saccharides of the poly-N-acetyllactosamine series. J. Embryol Exp Morph 1985, 87:115-128.
40. Kemler R., Bainet C., Eisen H., Jacob F. Surface antigen in early differentiation. Proc Natl Acad Sci 1977, 74:4449-4452.
41. Johnson L.V. Wheat germ agglutinin induces compaction- and cavitation-like events in two-cell mouse embryos. Dev Biol 1986, 113:1-9.
42. Dealtry C.B., Sellens M.H. Lectin-induced abnormalities of mouse blastocyst hatching and outgrowth in vitro. Mol Reprod Dev 1990, 26:24-29.
43. Fenderson B.A., Zehavi U., Hakomori S.-I. A multivalent lacto-N-fucopentose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective. J Exp Med 1984, 160:1591-1596.
44. Armant D.R., Kaplan H.A., Lennarz W.J. N-linked glycoprotein bosynthesis in the developing mouse embryo. Dev Biol 1986, 113:228-237.
45. Patsos G., Hebbe-Viton V., San Martin R., Paraskeva C., Gallagher T., Corfield A. Action of a library of O-glycosylation inhibitors on the growth of human colorectal cancer cells in culture. Biochem Soc Trans 2005, 33721-33723.
46. Murrey H.E., Gama C.I., Kalovidouris S.A., Luo W.-I., Driggers E.M., Porton B., et al. Protein fucosylation regulates synapsin Ia/Ib expression and neuronal morphology in primary hippocampal neurons. Proc Natl Acad Sci 2006, 103:21-26.
47. Haltiwanger RS, Lowe JB. Role of glycosylation in development 2004;73:491-537.
48. Caffaro C.E., Hirschberg C.B. Nucleotide sugar transporters of the Golgi apparatus: from basic science to diseases. Acc Chem Res 2006, 39:805-812.
49. Schachter H., Freeze H.H. Glycosylation diseases: Quo vadis?. Biochim Biophys Acta 2009, 1792:925-930.
50. Ten Hagen K.G., Tran D.T., Gerken T.A., Stein D.S., Zhang Z. Functional characterization and expression analysis of members of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family from Drosophila melanogaster. J Biol Chem 2003, 278:35039-35048.
51. Ten Hagen K.G., Tran D. A UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase is essential for viability in Drosophila melanogaster. J Biol Chem 2002, 277:22616-22622.
52. Schwientek T., Bennett E.P., Flores C., Thacker J., Hollmann M., Reis C.A., et al. Functional characterization of subfamilies of putative GalNAc:polypeptide N-acetylgalactosaminyltransferase in Drosophila melanogaster, Caenorhabditis elegans and mammals. J Biol Chem 2002, 277:22623-22638.
53. Tian E., Ten Hagen K.G. A UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase is required for epithelial tube formation. J Biol Chem 2007, 282:606-614.
54. Lin Y.-R., Reddy B.V.V.G., Irvine I.D. Requirement for a core 1 galactosyltransferase in the Drosophila nervous system. Dev Dynam 2008, 237:3703-3714.
55. Xia L., Ju T., Westmuckett A., An g., Ivanciu L., McDaniel J.M., et al. Defective angiogensis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J Cell Biol 2004, 164:451-459.
56. Alexander W.S., Viney E.M., Zhang J.-G., Metcalf D., Kauppi M., Hyland C.D., et al. Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene. Proc Natl Acad Sci 2006, 103:16442-16447.
57. Fu J., Gerhardt H., McDaniel J.M., Xia B., Liu X., Ianciu L., et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest 2008, 118:3725-3737.
58. Zhang L., Zhang Y., Ten Hagen K.G. A mucin-type O-glycosyltransferase modulates cell adhesion during Drosophila development. J Biol Chem 2008, 283:34076-34086.
59. Herr P., Korniychuk G., Yamamoto Y., Grubisic K., Oelgeschlager M. Regulation of TGF-βsignaling by N-acetylgalactosaminyltransferase-like 1. Develop 2008, 135:1813-1822.
60. Ichikawa S., Sorenson A.H., Austin A.M., Mackenzie D.S., Fritz T.A., Moh A., et al. Ablation of Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (FgF23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrin 2009, 150:2543-2550.
61. MMRC Strain Detail Sheet: 011647-129S5-Galnt10Gt(neo)78Lex/Mmnc.
62. Hennet T., Hagen F.K., Tabak L.A., Marth J.D. T-cell specific deletion of a polypeptide N-acetylgalactosaminyltransferase gene by site-directed recombination. Proc Natl Acad Sci 1995, 92:12070-12074.
63. Dausset J., Moullec J., Bernard J. Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (anti-Tn). Blood 1959, XIV:1079-1093.
64. Ju T., Cummings R.D. Chaperone mutation in Tn syndrome. Nature 2005, 437:152.
65. Eijgenraam J.W., van Kooten C. IgA1 glycosylation in IgA nephrophathy: as sweet as it can be. Kidney Int 2008, 73:1106-1108.
66. Iwase H., Tanaka A., Hiki Y., Kokubo T., Sano T., Ishii-Karakasa I., et al. Analysis of the microheterogeneity of the IgA1 hinge glycopeptides having multiple O-linked oligosaccarides by capillary electrophoresis. Analyt Biochem 2001, 288:22-27.
67. Gharavi A.G., Moldoveanu Z., Wyatt R.J., Barker C.V., Woodford S.Y., Lifton R.P., et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 2008, 19:1008-1014.
68. Kiryluk K, Gharavi AG, Izzzi C, Scolari F. IgA nephropathy-the case for a genetic basis becomes stronger. Nephrol Dial Tranplant 2009; advanced access: doi:1093/ndt/gfp593.j.
69. Suzuki H., Fan R., Zhang Z., Brown R., Hall S., Julian B.A., et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009, 119:1668-1677.
70. Li G.-S., Zhang H., Lv J.-C., Shen Y., Wang H.Y. Variants of the C1GALT1 gene are associated with genetic susceptibility to IgA nephropathy. Kidney Int 2007, 71:448-453.
71. Sprecher E. Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification. J Invest Derm 2009; advance online: doi:10.1038/jid.2009.337.
72. Kato K., Jeanneau C., Tarp M.A., Benet-Pages A., Lorenz-Depiereux B., Bennett E.P., et al. Polypeptide GalNAc-transferase T3 and Familial tumoral calcinosis. J Biol Chem 2006, 281:18370-18377.
73. Sellers T.A., Huang Y., Cunningham J., Goode E.L., Sutphen R., Vierkant R.A., et al. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidem Biomarkers Prev 2008, 17:397-404.
74. O'Halloran A.M., Patterson C.C., Horan P., Maree A., Curtin R., Stanton A., et al. Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2). J Throm Thrombolys 2009, 27:175-184.
75. Guda K., Moinova H., He J., Jamison O., Ravi L., Natale L., et al. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc Natl Acad Sci 2009, 106:12921-12925.
76. Velcich A., Yang W., Heyer J., Fragale A., Nicholas C., Viani S., et al. Colorectal cancer in mice genetically deficient in the mucin MUC2. Science 2002, 295:1726-1729.
77. An G., Wei B., Xia B., McDaniel J.M., Ju T., Cummings R.D., et al. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med 2007, 204:1417-1429.
78. Aoki K., Porterfield M., Lee S.S., Dong B., Nguyen K., McGlamry K.H., et al. The diversity of O-linked glycans expressed during Drosophila melanogaster development reflects state- and tissue-specific requirements for cell signaling. J Biol Chem 2008, 283:30385-30400.
79. Julenius K., Molgaard A., Gupta R., Brunak S. Prediction, conservation analysis and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 2004, 15:153-164.
80. Chen Y.-Z., Tang Y.R., Sheng Z.Y., Zhang Z. Prediction of mucin-type O-glycosylation sites in mammalian proteins using the composition of k-spaced amino acid pairs. BMC Bioinform 2008, 9:101-113.
81. Sakaki K., Nagamine N., Sakakibara Y. Support vector machine prediction of N- and O-glycosylation sites using whole sequence information and subcellular localization. Trans Bioinform 2009, 2:25-35.
82. Lu L., Niu B., Zhao J., Liu L., Lu W.-C., Liu X.J., et al. GalNAc-transferase specificity predition based on feature selection method. Peptides 2009, 30:359-364.
83. Gerkin T.A., Raman J., Fritz T., Jamison O. Identification of common and unique peptide substrate preferences for UDP-GalNAc:polypeptide α- N acetylgalactosaminyltransferases T1 and T2 derived rom oriented random peptide substrates. J Biol Chem 2006, 281:32403-32416.
84. Perrine CL, Ganguli A, Wu P, Bertozzi CR, Fritz TA, Raman J, Tabak LA, Gerken TA, Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-OSer/Thr-binding site in its catalytic domain not found in ppGalNAcT1 or T2. 2009;284:20387-97.
85. Fritz T.A., Hurley J.H., Trinh L.-B., Shiloach J., Tabak L.A. The beginnings of mucin biosynthesis: the crystal structure of UDP-GalNAc:polypeptide α-N-acetylgalactosaminyltranserase-T1. Proc Natl Acad Sci 2004, 101:15307-15312.
86. Fritz T.A., Raman J., Tabak L.A. Dynamic association between the catalytic and lectin domains of human UDP-GalNAc:polypeptide α-N-acetylgalactosaminyltranserase-2. J Biol Chem 2006, 281:8613-8619.
87. Kubota T., Shiba T., Sugioka S., Furukawa S., Sawaki H., Kato R., et al. Structural basis of carbohydrate transfer activity by human UDP-GalNAc:polypeptide α-N-acetylgalactosaminyltranserase (pp-GalNAc-T10). J Mol Biol 2006, 359:708-727.
88. Gross B.J., Swoboda J.G., Walker S. A strategy to discover inhibitors of O-linked glycosylation. J Am Chem Assoc 2008, 130:440-441.
89. Yoshinao W., Michiko T. Tackling difficulties in the determination of O-glycosylation sites: approaches to mucin-type glycoproteins. Trends Glycosci Glycotech 2008, 20:69-80.
90. Jensen PH, Kolarich D, Packer NH. Mucin-type glycosylation- putting the pieces together. FEBS J 2009; doi:10.1111/j.1742-4658.07429.x.
91. Gerken T.A., Owens C.L., Pasumarty M. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptides. J Biol Chem 1997, 272:9709-9719.
92. Singh P.K., Hollingsworth M.A. Cell surface-associated mucins in signal transduction. Trends Cell Biol 2006, 16:467-476.
93. Wagner K.W., Punnoose E.A., Januario Th., Lawrence D.A., Pitti R.M., Lancaster K., et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand. Apo2L/TRAIL 2007, 13:1070-1077.
94. Van Dyken S.J., Green R.S., Marth J.D. Structural and mechanistic features of protein O-glycosylation linked to CD8+ T-cell apoptosis. Mol Cell Biol 2007, 27:96-1111.
95. Workman H.C., Sweeney C., Carraway K.L. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Cancer Res 2009, 69:2845-2852.
96. Livet J., Weissman T.A., Kang H., Draft R.W., Lu J., Bennis R.A., et al. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 2007, 56-62.
97. Laughlin S.T., Bertozzi C.R. Imaging the glycome. Proc Natl Acad Sci 2009, 106:12-17.
98. Dehennaut V., Hanoulle X., Bodart J.-F., Vilain J.-P., Michalski J.C., Landrieu I., et al. Microinjection of recombinant O-GlcNAc transferase potentiates Xenopus oocytes M-phase entry. Biochem Biophys Res Commun 2008, 369:539-546.
99. Marth J.D. A unified vision of the building blocks of life. Nature Cell Biol 2008, 10:1015-1016.
100. Ten Hagen K.G., Zhang L., Tian E., Zhang Y. Glycobiology on the fly: developmental and mechanistic insights from Drosophila. Glycobiol 2009, 19:102-111.